A newly discovered probiotic bacteria called Bacillus altitudinis JSHY-074 can protect farmed shrimp from deadly Vibrio disease without antibiotics, according to Gram Research analysis. In laboratory tests, the probiotic achieved an 88.58% inhibition rate against harmful bacteria, and when shrimp were fed this probiotic and exposed to the disease, 70% survived within 5 days with pathogen levels dropping by 5,942 times. This discovery offers a sustainable alternative to antibiotic treatments in aquaculture.
Scientists in China discovered a new type of beneficial bacteria called Bacillus altitudinis JSHY-074 that can protect farmed shrimp from a deadly disease without using antibiotics. When researchers tested this probiotic in shrimp farms, it helped 70% of shrimp survive a dangerous infection and reduced harmful bacteria levels by nearly 6,000 times. This discovery is important because it offers a safer, more environmentally friendly way to keep shrimp healthy while reducing the overuse of antibiotics that creates drug-resistant bacteria. The findings suggest this probiotic could become a standard feed additive in aquaculture worldwide.
Key Statistics
A 2026 research study found that Bacillus altitudinis JSHY-074 probiotic bacteria created expanding inhibition zones against Vibrio parahaemolyticus, growing from 12 millimeters at 6 hours to 30 millimeters at 96 hours of co-culture.
When Pacific white shrimp were fed Bacillus altitudinis JSHY-074 and exposed to highly lethal Vibrio disease, 70% survived within 5 days and harmful bacteria in their organs decreased by 5,942-fold, from 61.2 million to 10,300 copies.
A 2026 research article identified nine gene clusters in Bacillus altitudinis JSHY-074 responsible for producing antimicrobial compounds, with lichenysin preliminarily identified as the primary active ingredient against Vibrio parahaemolyticus.
At an inoculum density of 1.0 × 10⁸ CFU/mL, Bacillus altitudinis JSHY-074 achieved an 88.58% inhibition rate against Vibrio parahaemolyticus strain SHY1669 after 72 hours of co-culture.
The Quick Take
- What they studied: Whether a newly discovered beneficial bacteria could protect farmed shrimp from a deadly disease caused by harmful Vibrio bacteria, and whether it could replace antibiotic treatments.
- Who participated: Pacific white shrimp (Litopenaeus vannamei) raised in aquaculture settings were exposed to the deadly Vibrio disease and fed the probiotic bacteria to test its protective effects.
- Key finding: Shrimp fed the probiotic bacteria had a 70% survival rate when exposed to the deadly disease, and the harmful bacteria in their organs dropped by 5,942 times compared to untreated shrimp.
- What it means for you: If you eat farmed shrimp, this research suggests future shrimp could be raised without heavy antibiotic use, meaning safer seafood and less environmental pollution. However, this is early-stage research that needs more testing before widespread use.
The Research Details
Researchers isolated a new strain of beneficial bacteria (Bacillus altitudinis JSHY-074) from coastal aquaculture environments in China. They identified it using genetic testing and analyzed its complete genetic code to understand how it works. The team then tested whether this bacteria could kill the harmful Vibrio parahaemolyticus bacteria in laboratory conditions by growing them together and measuring the size of the kill zones around the beneficial bacteria.
Next, they conducted a real-world test by feeding the probiotic bacteria to Pacific white shrimp and then deliberately exposing them to the deadly Vibrio disease. They measured how many shrimp survived and how much of the harmful bacteria remained in the shrimp’s organs (hepatopancreas) after infection. This approach allowed researchers to see if the probiotic worked both in test tubes and in living animals.
This research design is important because it moves beyond simple laboratory tests to show real-world effectiveness. By testing the bacteria both in controlled lab conditions and in actual shrimp, the researchers demonstrated that the probiotic doesn’t just kill harmful bacteria in a dish—it actually protects living animals from disease. This two-step approach gives confidence that the probiotic could work in commercial shrimp farms.
The study used rigorous scientific methods including genetic sequencing to confirm the bacteria’s identity, whole-genome analysis to understand its mechanisms, and quantitative measurements of bacterial inhibition. The research was published in a peer-reviewed journal focused on aquatic animal health. However, the study does not specify the exact number of shrimp tested, which limits our ability to assess the statistical power of the survival results. The work represents early-stage research that would benefit from larger-scale validation studies.
What the Results Show
The Bacillus altitudinis JSHY-074 bacteria showed powerful activity against the harmful Vibrio parahaemolyticus bacteria. When grown together in the laboratory, the beneficial bacteria created expanding kill zones around itself—starting at 12 millimeters after 6 hours and growing to 30 millimeters by 96 hours. At high concentrations, the probiotic achieved an 88.58% inhibition rate after 72 hours, meaning it killed or prevented the growth of nearly 9 out of 10 harmful bacteria.
When shrimp were fed this probiotic and then exposed to the deadly Vibrio disease, the results were dramatic. Seventy percent of the treated shrimp survived the infection within 5 days. More importantly, the amount of harmful bacteria in the shrimp’s hepatopancreas (a vital organ) dropped from 61.2 million copies to just 10,300 copies—a reduction of 5,942 times. This massive decrease in pathogen load suggests the probiotic was extremely effective at controlling the infection inside the shrimp’s body.
Genetic analysis revealed that the beneficial bacteria produces nine different clusters of genes responsible for making compounds that kill harmful bacteria. The primary active ingredient appears to be a substance called lichenysin, which is known to have antimicrobial properties. This discovery helps explain why the probiotic is so effective against the deadly Vibrio disease.
The research identified that Bacillus altitudinis JSHY-074 is the first strain of this species shown to fight the highly lethal Vibrio disease in shrimp. The bacteria’s ability to produce multiple antimicrobial compounds (nine gene clusters) suggests it has multiple ways of attacking harmful pathogens, which could make it harder for bacteria to develop resistance. The fact that this beneficial bacteria was isolated from natural coastal aquaculture environments indicates it may already be adapted to shrimp farming conditions.
This is the first report of Bacillus altitudinis showing antagonistic activity against the highly lethal Vibrio parahaemolyticus strain that causes disease in farmed shrimp. While probiotics have been used in aquaculture before, this specific strain and its effectiveness against this particular deadly disease represents a novel finding. The 70% survival rate and 5,942-fold reduction in pathogen load are substantial improvements that suggest this probiotic may be more effective than some existing approaches.
The study does not specify the exact number of shrimp tested in the challenge experiment, making it difficult to assess whether the 70% survival rate is statistically reliable or could have occurred by chance. The research was conducted in controlled laboratory and farm conditions, which may not perfectly reflect real-world commercial shrimp farming with its variable conditions and mixed bacterial populations. The study focused only on one strain of harmful Vibrio bacteria, so effectiveness against other disease-causing strains is unknown. Long-term safety data and potential effects on other beneficial bacteria in shrimp or the environment were not evaluated. Additionally, the optimal dosage and feeding duration for maximum protection were not determined.
The Bottom Line
Based on this research, Bacillus altitudinis JSHY-074 shows strong promise as a probiotic feed additive for shrimp farming. The evidence suggests it could reduce reliance on antibiotics while improving shrimp survival rates during disease outbreaks. However, confidence in these recommendations is moderate because the study needs validation through larger-scale trials in commercial farms. Before widespread adoption, additional research should confirm safety for other aquatic organisms and the environment, determine optimal dosing protocols, and test effectiveness against multiple disease-causing bacteria strains.
Shrimp farmers and aquaculture companies should care most about this research, as it offers a practical alternative to antibiotics that could reduce costs and improve sustainability. Seafood consumers benefit indirectly by potentially receiving shrimp raised with fewer antibiotics. Environmental advocates should care because reducing antibiotic use in aquaculture decreases pollution and slows the development of antibiotic-resistant bacteria. Regulatory agencies overseeing aquaculture should monitor this research for potential approval as a feed additive. This research is less relevant for people who don’t consume farmed shrimp or work in aquaculture.
If this probiotic moves forward to commercial use, shrimp farmers could potentially see benefits within weeks of adding it to feed, as the study showed protective effects within 5 days of exposure to disease. However, realistic timelines for regulatory approval and commercial availability are typically 2-5 years, depending on additional safety testing and regulatory requirements in different countries.
Frequently Asked Questions
Can probiotics replace antibiotics in shrimp farming?
Research shows Bacillus altitudinis JSHY-074 probiotic achieved 70% survival in shrimp exposed to deadly Vibrio disease and reduced harmful bacteria by 5,942 times. While promising, this early-stage research needs larger commercial trials before widespread replacement of antibiotics.
How does this probiotic bacteria kill harmful pathogens in shrimp?
The probiotic produces nine different antimicrobial compounds, with lichenysin identified as the primary active ingredient. These compounds create expanding kill zones around the beneficial bacteria, achieving 88.58% inhibition of harmful Vibrio bacteria within 72 hours.
Is this probiotic safe for farmed shrimp and the environment?
The bacteria was isolated from natural coastal aquaculture environments and showed no adverse effects in the study. However, comprehensive long-term safety data for other aquatic organisms and environmental impacts have not yet been evaluated in published research.
How quickly does the probiotic protect shrimp from disease?
Shrimp fed the probiotic showed protective benefits within 5 days of exposure to deadly Vibrio disease, with 70% survival rates. However, optimal feeding duration and dosage protocols for maximum protection require further research.
What makes this probiotic better than existing aquaculture disease treatments?
Unlike antibiotics, this probiotic doesn’t create drug-resistant bacteria and is environmentally friendly. The 5,942-fold reduction in pathogen load and 70% survival rate suggest effectiveness comparable to or better than some existing approaches, with the added benefit of sustainability.
Want to Apply This Research?
- For aquaculture operations, track weekly disease incidence rates and shrimp mortality percentages before and after introducing the probiotic feed additive. Measure antibiotic usage in doses per batch of shrimp to quantify reduction in drug dependency.
- Aquaculture managers could implement a gradual transition from antibiotic-based disease prevention to probiotic supplementation by mixing the new feed additive into standard feed at recommended concentrations and monitoring shrimp health outcomes weekly.
- Establish a long-term tracking system that monitors monthly survival rates, disease outbreak frequency, antibiotic usage amounts, and feed conversion efficiency. Compare these metrics across multiple production cycles to determine if the probiotic maintains consistent protective benefits and cost savings over time.
This research represents early-stage findings about a potential probiotic for shrimp aquaculture. While the results are promising, this study has not yet been validated through large-scale commercial trials or regulatory approval processes. The findings apply specifically to Pacific white shrimp and the Vibrio parahaemolyticus strain tested. Before commercial use, additional research is needed to confirm safety for other aquatic species, environmental impacts, optimal dosing protocols, and effectiveness against other disease-causing bacteria. Aquaculture operators should consult with veterinarians and regulatory agencies before implementing any new disease prevention strategies. This information is for educational purposes and should not replace professional aquaculture management advice.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.